Sign inJoin waitlistJoin the waitlist

Araz Marachelian

Physician · Childrens Hospital Los Angeles

Credentials: · · · · ·

History

Childrens Hospital Los Angeles
Present

Pediatric Hematology-Oncology
2003–2004
Pediatrics
2000–2003
Univ of California, Irvine School of Medicine
1996–2000

Research

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
Nature Medicine · 2023 · 115 citations
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New…
Journal of Clinical Oncology · 2016 · 105 citations
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Journal of Clinical Oncology · 2019 · 99 citations

Katherine Matthay
23 papers
Julie Park
22 papers
Hiroyuki Shimada
17 papers
JV
Judith Villablanca
17 papers
John Maris
14 papers
Meaghan Granger
14 papers
Steven DuBois
14 papers
Fariba Goodarzian
13 papers
Susan Cohn
11 papers
HL
Hollie Lai
10 papers
Brian Weiss
8 papers
Rochelle Bagatell
8 papers

Clinical trials

Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2013–2027
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Study chair · Active not recruiting · Phase 1
New Approaches to Neuroblastoma Therapy Consortium
2019–2026
ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma
Study chair · Completed · Phase 1, Phase 2
United Therapeutics
2012–2014
MIBG With Dinutuximab +/- Vorinostat
Study director · Completed · Phase 1
New Approaches to Neuroblastoma Therapy Consortium
2018–2024